Publications by authors named "Chee Kay Cheung"

Claim this Profile
E
Evaluating Sibeprenlimab in IgA Nephropathy - Rationale and Baseline Data from the VISIONARY Trial.
Vlado Perkovic, Jonathan Barratt, Richard Lafayette, Adrian Liew, Yusuke Suzuki, Chee Kay Cheung

Kidney Int Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.
Vlado Perkovic, Hernán Trimarchi, Vladimir Tesar, Richard Lafayette, Muh Geot Wong, Chee Kay Cheung

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How should we target and reduce the production of pathogenic IgA in IgAN?
Chee Kay Cheung, Yusuke Suzuki

Nephrol Dial Transplant· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.
Philipp Gauckler, Anna Matyjek, Seleni Kapsia, Smaragdi Marinaki, Luis F Quintana, Chee Kay Cheung

J Am Soc Nephrol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated primary and secondary care optimizes the management of people with CKD-the LUCID project.
Rupert W Major, Niraj Lakhani, Yaseen Ahmed, Jade Atkin, Richard Baines, Chee Kay Cheung

Clin Kidney J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pathogenesis of IgA nephropathy and implications for treatment.
Chee Kay Cheung, Suceena Alexander, Heather N Reich, Haresh Selvaskandan, Hong Zhang

Nat Rev Nephrol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of albuminuria or proteinuria for risk prediction in IgAN.
Chee Kay Cheung, Jonathan Barratt

Nephrol Dial Transplant· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National recommendations for the management of children and young people with IgA vasculitis: a best available evidence, group agreement-based approach.
Louise Oni, Caroline Platt, Matko Marlais, Liza McCann, Farah Barakat, Chee Kay Cheung

Arch Dis Child· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting APRIL in the treatment of glomerular diseases.
Chee Kay Cheung, Jonathan Barratt, Richard Lafayette, Adrian Liew, Yusuke Suzuki

Kidney Int· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Rapidly Changing Treatment Landscape of IgA Nephropathy.
Chee Kay Cheung, Jonathan Barratt

Semin Nephrol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting APRIL in the Treatment of IgA Nephropathy.
Chee Kay Cheung, Jonathan Barratt, Kevin Carroll, Richard A Lafayette, Adrian Liew

Clin J Am Soc Nephrol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Treatment Paradigms: Primary IgA Nephropathy.
Haresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung

Kidney Int Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies.
Chee Kay Cheung, Jonathan Barratt, Adrian Liew, Hong Zhang, Vladimir Tesar

Front Nephrol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of complement in glomerulonephritis-are novel therapies ready for prime time?
Chee Kay Cheung, John P Dormer, Jonathan Barratt

Nephrol Dial Transplant· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.
Rona M Smith, Rachel B Jones, Ulrich Specks, Simon Bond, Marianna Nodale, Chee Kay Cheung

Ann Rheum Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First do no harm: systemic glucocorticoids should not be used for the treatment of progressive IgA nephropathy.
Chee Kay Cheung, Jonathan Barratt

Kidney Int· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgA nephropathy: an overview of drug treatments in clinical trials.
Haresh Selvaskandan, Guillermo Gonzalez-Martin, Jonathan Barratt, Chee Kay Cheung

Expert Opin Investig Drugs· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further Evidence for the Mucosal Origin of Pathogenic IgA in IgA Nephropathy.
Chee Kay Cheung, Jonathan Barratt

J Am Soc Nephrol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-COV-2 vaccine responses in renal patient populations.
Rona M Smith, Daniel J Cooper, Rainer Doffinger, Hannah Stacey, Abdulrahman Al-Mohammad, Chee Kay Cheung

BMC Nephrol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological drivers of IgA nephropathy: Exploring the mucosa-kidney link.
Haresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung

Int J Immunogenet· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy.
Katrin Scionti, Karen Molyneux, Haresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung

Glomerular Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management.
Haresh Selvaskandan, Sufang Shi, Sara Twaij, Chee Kay Cheung, Jonathan Barratt

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Update on the Current State of Management and Clinical Trials for IgA Nephropathy.
Chee Kay Cheung, Arun Rajasekaran, Jonathan Barratt, Dana V Rizk

J Clin Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab in Membranous Nephropathy.
Philipp Gauckler, Jae Il Shin, Federico Alberici, Vincent Audard, Annette Bruchfeld, Chee Kay Cheung

Kidney Int Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance rituximab treatment for ANCA-associated vasculitis: to be continued?
Chee Kay Cheung, Stephen P McAdoo

Rheumatology (Oxford)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis